Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Folate-Modified Albumin Nanoparticles Deliver Curcumin to Trigger Glioma Cell Death

2 hours ago 8

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

A research team led by Lixia Yang at Shaoxing People’s Hospital has designed an albumin-based nanocarrier system engineered to deliver curcumin directly to glioma cells. Described in an original research article published in Frontiers in Oncology, the targeted therapeutic formulation aims to suppress brain cancer cells by simultaneously activating ferroptosis and apoptosis pathways.

The researchers formulated folate-modified bovine serum albumin nanoparticles loaded with curcumin, designated as Cur@BSA-FA, using the desolvation method. Physicochemical characterization revealed that the synthesized nanoparticles possessed an average diameter of 122.4 nanometers, a negative Zeta potential, high drug-loading efficiency, and a sustained drug-release profile.

The team evaluated the formulation’s physical properties through multiple analytical techniques, including transmission electron microscopy and Fourier-transform infrared spectroscopy.

In laboratory experiments testing cellular activity, the investigators administered the Cur@BSA-FA nanoparticles to cultured C6 glioma cells. Using cell counting kit-8 assays, scratch wound healing migration tests, and colony formation assays, the researchers observed that the nanotherapeutic agent significantly suppressed glioma cell proliferation, wound closure, and colony formation in a dose-dependent manner.

Biochemical analyses demonstrated that the treatment triggered dual mechanisms of regulated cell death within the C6 glioma cells.

These collective biomarker alterations indicated that Cur@BSA-FA induced synergistic ferroptosis and apoptosis in the tested cancer cells. To assess therapeutic potential in living systems, the authors tested the formulation in subcutaneous xenograft tumor models, where the nanocarrier system significantly inhibited tumor growth while demonstrating favorable in vivo biosafety.

The investigators concluded that Cur@BSA-FA mediates tumor targeting at least partially through folate receptor-mediated endocytosis. While these initial findings highlight a promising nanotherapeutic strategy against glioma, the researchers noted that the platform warrants further evaluation and validation in orthotopic glioma models before clinical potential can be determined.

Subject of Research: Targeted albumin nanoparticles delivering curcumin to induce glioma cell death

Article Title: Folic acid-modified bovine serum albumin targeted delivery of curcumin induces ferroptosis and apoptosis in glioma cells

Article References: Qian, Y., Peng, W., Mao, Y., Huang, C., & Yang, L. (2026). Folic acid-modified bovine serum albumin targeted delivery of curcumin induces ferroptosis and apoptosis in glioma cells. Frontiers in Oncology, 16, Article 1968983. https://doi.org/10.3389/fonc.2026.1968983

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1968983

Keywords: curcumin, Cur@BSA-FA, bovine serum albumin, folic acid, glioma, C6 glioma cells, ferroptosis, apoptosis, nanoparticles, desolvation method, subcutaneous xenograft, reactive oxygen species, malondialdehyde, lipid hydroperoxide, GPX4, Bcl-2, folate receptor endocytosis

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway